PRCT Oct 2024 42.500 call
| Previous close | 13.80 |
| Open | N/A |
| Bid | 26.00 |
| Ask | 30.50 |
| Strike | 42.50 |
| Expiry date | 2024-10-18 |
| Day's range | 13.80 - 13.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
Investor's Business DailyIntuitive Surgical, IBD Stock Of The Day, Feels Its Way Toward Buy Point
Intuitive Surgical is IBD Stock Of The Day as the robotic surgery pioneer nears a buy point on hopes for its da Vinci 5 that lets surgeons feel each incision.
GlobeNewswirePROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 2024 Leerink Partners Healthcare Crossroads Conference in Austin, Texas. Management is scheduled to present on Wednesday, May 29 at 10:20 a.m. Eastern Time. Additionally, members of management will present at th
- GlobeNewswire
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
Data from the Icahn School of Medicine at Mount Sinai and Potomac Urology presented at the 2024 AUA Annual Meeting highlight Aquablation therapy’s potential to become the new standard of care in BPH for prostates of all sizesSAN JOSE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced long-term, real-world data sho
